IriSys contract with NCI doubled to $6M for clinical trial materials

IriSys, LLC was awarded a $6 million increase in its five-year prime vendor contract with the National Cancer Institute for manufacturing clinical trial materials, doubling the ceiling.

“IriSys' consistent delivery of quality clinical trials materials to NCI on a timely basis is an example of our client-focused approach.”biospace.com

• 1 source
• biospace.comIriSys, Inc. Contract With NCI For Manufacturing Clinical Trial Materials Is Doubled In ValueDan SamorodnitskyApr 20, 2017

Summarized from public sources; check the original articles before acting on it.